[Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].

作者
Fengan Ding,Biao Liu,Xinhua Zhang,Yan Xu,Bo Yu,Rusong Zhang,Yan He,Heng‐hui Ma,Zhenfeng Lu,Xiaojun Zhou
出处
期刊:PubMed [National Institutes of Health]
卷期号:41 (3): 145-50 被引量:1
标识
DOI:10.3760/cma.j.issn.0529-5807.2012.03.001
摘要

OBJECTIVE: To evaluate the prognostic significance of a new grading and scoring system (based on the new IASLC/ATS/ERS classification) in stage I pulmonary adenocarcinoma, as compared with the WHO grading system. METHODS: The clinicopathologic characteristics of 125 patients with stage I pulmonary adenocarcinoma primarily treated by surgical resection were reviewed retrospectively. All cases were classified according to the new IASLC/ATS/ERS classification and graded into three prognostic groups based on the new classification, the Sica scoring system and the WHO grading system, respectively. The differences in prognosis of the three groups were analyzed. RESULTS: There was a statistically significant correlation between the new grading system and the WHO grading system (P = 0.000). Both of them showed negative correlation with overall survival. The new scoring system however better correlated with disease recurrence and/or metastasis (P = 0.855, P = 0.073 versus P = 0.011). According to univariate Log-rank test, the prognosis correlated with tumor size (P = 0.004), clinical stage (P = 0.000), the WHO grading (P = 0.020), the new grading system (P = 0.000), the new scoring system (P = 0.000), vascular invasion (P = 0.021), and recurrence and/or metastasis (P = 0.000). The Cox regression analysis demonstrated that clinical stage (P = 0.014), the new grading system (P = 0.047), the new scoring system (P = 0.043), and recurrence and/or metastasis (P = 0.018) were significantly independent poor prognostic factors. CONCLUSIONS: The new grading and scoring system shows good correlation with the WHO grading system. Compared with the WHO grading system, the new scoring system based on the new IASLC/ATS/ERS classification provides valuable information in categorizing stage I pulmonary adenocarcinoma cases with different risks of disease recurrence, tumor metastasis and prognosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
miaomiao发布了新的文献求助10
1秒前
刘畅完成签到 ,获得积分10
2秒前
SciGPT的应助被li采纳,获得10
2秒前
Cinderella完成签到 ,获得积分10
2秒前
3秒前
小蘑菇的应助被砥砺前行采纳,获得10
3秒前
心木发布了新的文献求助10
3秒前
3秒前
ljy完成签到 ,获得积分10
5秒前
科研通AI6.4的应助被大华采纳,获得30
5秒前
5秒前
penguin完成签到,获得积分10
5秒前
付艳完成签到,获得积分10
5秒前
7秒前
小巧的中蓝完成签到 ,获得积分10
8秒前
yuko完成签到 ,获得积分10
9秒前
lps888666完成签到,获得积分10
9秒前
AAA完成签到,获得积分10
10秒前
10秒前
哈47发布了新的文献求助10
10秒前
spinor完成签到,获得积分10
10秒前
xiaolong发布了新的文献求助10
11秒前
12秒前
dxl完成签到,获得积分10
12秒前
13秒前
里予完成签到,获得积分10
15秒前
17秒前
林结衣完成签到,获得积分10
19秒前
小荷才露尖尖角的应助被杨波采纳,获得50
20秒前
可爱的函函的应助被成就书芹采纳,获得10
22秒前
外向的沛柔完成签到,获得积分10
22秒前
lps888666发布了新的文献求助10
22秒前
砥砺前行发布了新的文献求助10
22秒前
专注的荧完成签到 ,获得积分10
22秒前
feixiangyyq完成签到,获得积分10
22秒前
慈祥的丹寒完成签到 ,获得积分10
23秒前
25秒前
王诗琪完成签到,获得积分10
26秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568